Allianz Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,000
| Closed | -$1.08M | – | 2529 |
|
|
2021
Q1 | $1.08M | Buy |
5,000
+1,000
| +25% | +$188K | ﹤0.01% | 1612 |
|
|
2020
Q4 | $462K | Hold |
4,000
| – | – | ﹤0.01% | 1649 |
|
|
2020
Q3 | $390K | Hold |
4,000
| – | – | ﹤0.01% | 1654 |
|
|
2020
Q2 | $490K | Buy |
+4,000
| New | +$454K | ﹤0.01% | 2061 |
|
|
2019
Q4 | – | Sell |
-3,765
| Closed | -$435K | – | 2898 |
|
|
2019
Q3 | $435K | Sell |
3,765
-4,400
| -54% | -$668K | ﹤0.01% | 2414 |
|
|
2019
Q2 | $1.41M | Sell |
8,165
-615
| -7% | -$106K | ﹤0.01% | 2019 |
|
|
2019
Q1 | $1.48M | Buy |
8,780
+690
| +9% | +$103K | ﹤0.01% | 1954 |
|
|
2018
Q4 | $783K | Sell |
8,090
-2,000
| -20% | -$262K | ﹤0.01% | 2122 |
|
|
2018
Q3 | $1.74M | Hold |
10,090
| – | – | ﹤0.01% | 1999 |
|
|
2018
Q2 | $1.41M | Hold |
10,090
| – | – | ﹤0.01% | 2093 |
|
|
2018
Q1 | $1.14M | Hold |
10,090
| – | – | ﹤0.01% | 2162 |
|
|
2017
Q4 | $1.33M | Hold |
10,090
| – | – | ﹤0.01% | 2151 |
|
|
2017
Q3 | $1.02M | Hold |
10,090
| – | – | ﹤0.01% | 2246 |
|
|
2017
Q2 | $1.01M | Sell |
10,090
-110
| -1% | -$11.8K | ﹤0.01% | 2215 |
|
|
2017
Q1 | $1.24M | Sell |
10,200
-2,485
| -20% | -$305K | ﹤0.01% | 2172 |
|
|
2016
Q4 | $1.42M | Buy |
+12,685
| New | +$1.53M | ﹤0.01% | 2097 |
|
Other funds holding GWPH
Allianz Asset Management's GWPH Position: Q2 2021 in Review
Allianz Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 5,000 shares — an estimated $1.08M sold.
Allianz Asset Management first reported a position in GWPH in Q4 2016 and held it in 16 quarters. The position peaked at $1.74M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Allianz Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Allianz Asset Management sold 5,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.08M.
- Allianz Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 16 quarters.
- Allianz Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.74M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.